Compound class:
Synthetic organic
Comment: LTGO-33 is a selective small molecule inhibitor of the voltage-gated sodium channel NaV1.8 [1]. The NaV1.8 channel is a validated molecular target for the treatment of peripheral pain disorders. LTGO-33 interacts at a novel site in the channel's voltage-sensor domain and inhibits channel opening.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
LTGO-33 is >600-fold selective for NaV1.8 over NaVs 1.1-1.7 and NaV1.9, with specificity for human NaV1.8 compared to rodent and dog orthologues [1]. It inhibits with similar potencies at closed and inactivated channels. |
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|